Organizer's

Oct. 14 (Fri.) ,2016 09:30-11:30

Annex Hall
F201

Simultaneous Interpretation

Human Gut Microbiota as Novel Therapeutic Targets

Microbes have crucial roles in human health and diseases. However, targeted strategies for promoting human health through the modification of either human-associated microbial communities or associated human-host targets have yet to be realized. In this session, we discuss new therapeutic strategies on the gut microbiota-related diseases.

Cordinator

Hiroshi Ohno

Group Director, RIKEN Center for Integrative Medical Sciences

Overview

Hiroshi Ohno

Group Director, RIKEN Center for Integrative Medical Sciences

Microbiome-based Approaches for the Regulation of Appetite

Gregory Lambert

CEO, TargEDys

Effects on Human Biofunction through the Alteration of the Intestinal Microbiota - The Relation between "Intestinal Microbiota Analysis by Using the Next-generation Sequencer" and "Gene Expression Profiling"-

Yuriko Oda

Researcher, Pharmaceutical & Healthcare Research Laboratories, Research & Development Management Headquarters, FUJIFILM

Diabetes, obesity and gut microbiota

Naoto Kubota

Associate Professor, Department of Clinical Nutrition Therapy, The University of Tokyo Hospital

Bacterio therapy for diseases & health

Takanori Kanai

Keio University School of Medicine Department of Gastroenterology and HepatologyProfessor of Medicine

Close Window